SPHS: Awaiting Regulatory Guidance for Topsalysin Phase 3 Study… – Zacks Small Cap Research
SPHS: Awaiting Regulatory Guidance for Topsalysin Phase 3 Study… Zacks Small Cap Research 03/29/2019. Download this Report (). By David Bautz, PhD. NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Sophiris Bio Inc. … Continue reading →